JeffreyAMorganMD

PubMed

• Phase II Study of Eribulin plus Pembrolizumab in Metastatic Soft-tissue Sarcomas: Clinical Outcomes and Biological Correlates.
  Candace L Haddox, Emanuele Mazzola, Jia-Ren Lin, Joanna Baginska, Allison Nau, Jason L Weirather, Adrian Marino-Enriquez, Jeffrey A Morgan, Priscilla Merriam, Andrew J...> ;Clinical Cancer Research. 2024 Apr 1
• 4 citations
  Concurrent inhibition of CDK2 adds to the anti-tumour activity of CDK4/6 inhibition in GIST.
  Inga-Marie Schaefer, Matthew L Hemming, Meijun Z Lundberg, Matthew P Serrata, Isabel Goldaracena, Ninning Liu, Peng Yin, Joao A Paulo, Steven P Gygi, Suzanne George, J...> ;British Journal of Cancer. 2022 Nov 1
• 3 citations
  Primary intra-abdominal melanoma arising in association with extracutaneous blue naevus: a report of two cases.
  Kabeer K. Shah, Andrew L. Folpe, Michael B. Miller, Jeffrey A. Morgan, Chandrajit P. Raut, Leona A. Doyle> ;Histopathology. 2021 Jan 1
• 15 citations
  A phase II multi-strata study of lurbinectedin as a single agent or in combination with conventional chemotherapy in metastatic and/or unresectable sarcomas.
  Gregory M. Cote, Edwin Choy, Tianqi Chen, Adrián Mariño-Enríquez, Jeffrey A. Morgan, Priscilla Merriam, Katherine Thornton, Andrew J. Wagner, Michael J. Nathenson, Geo...> ;European Journal of Cancer. 2020 Feb 1
• 36 citations
  Phase I Study of Rapid Alternation of Sunitinib and Regorafenib for the Treatment of Tyrosine Kinase Inhibitor Refractory Gastrointestinal Stromal Tumors
  César Serrano, Alessandro Leal, Yanan Kuang, Jeffrey A. Morgan, Constance M. Barysauskas, Jillian Phallen, Olivia Triplett, Adrián Mariño-Enríquez, Andrew J. Wagner, G...> ;Clinical Cancer Research. 2019 Dec 15
• 118 citations
  Levetiracetam versus phenytoin for second-line treatment of paediatric convulsive status epilepticus (EcLiPSE): a multicentre, open-label, randomised trial
  Mark D Lyttle, Naomi Rainford, Carrol Gamble, Shrouk Messahel, Amy Humphreys, Helen Hickey, Kerry Woolfall, Louise Roper, Joanne Noblet, Elizabeth Lee, Sarah Potter, P...> ;Lancet. 2019 May 25
• 145 citations
  Immunotherapy with single agent nivolumab for advanced leiomyosarcoma of the uterus: Results of a phase 2 study
  Eytan Ben-Ami, Constance M. Barysauskas, Sarah Solomon, Kadija Tahlil, Rita Malley, Melissa Hohos, Kathleen Polson, Margaret Loucks, Mariano Severgnini, Tara Patel, Am...> ;Cancer. 2017 Sep 1
• 68 citations
  Long-term follow-up results of the multicenter phase II trial of regorafenib in patients with metastatic and/or unresectable GI stromal tumor after failure of standard...
  Eytan Ben-Ami, Constance M. Barysauskas, M. von Mehren, Michael Heinrich, Christopher L. Corless, James E. Butrynski, Jeffrey A. Morgan, Andrew J. Wagner, Edwin Choy, ...> ;Annals of Oncology. 2016 Sep 1
• 43 citations
  KRAS and KIT Gatekeeper Mutations Confer Polyclonal Primary Imatinib Resistance in GI Stromal Tumors: Relevance of Concomitant Phosphatidylinositol 3-Kinase/AKT Dysreg...
  César Serrano, Yuexiang Wang, Adrián Mariño-Enríquez, Jen-Chieh Lee, Gloria Ravegnini, Jeffrey A. Morgan, Monica M. Bertagnolli, Carol Beadling, George D. Demetri, Chr...> ;Journal of Clinical Oncology. 2015 Aug 1
• 24 citations
  Biologic Activity of Autologous, Granulocyte–Macrophage Colony-Stimulating Factor Secreting Alveolar Soft-Part Sarcoma and Clear Cell Sarcoma Vaccines
  John M. Goldberg, David E. Fisher, George D. Demetri, Donna Neuberg, Stephen A. Allsop, Catia Fonseca, Yukoh Nakazaki, David M. Nemer, Chandrajit P. Raut, Suzanne Geor...> ;Clinical Cancer Research. 2015 Jul 15
• 48 citations
  Phase 1 study of oral abexinostat, a histone deacetylase inhibitor, in combination with doxorubicin in patients with metastatic sarcoma.
  Edwin Choy, Yael Flamand, Sriram Balasubramanian, James E. Butrynski, David C. Harmon, Suzanne George, Gregory M. Cote, Andrew J. Wagner, Jeffrey A. Morgan, Mint Siris...> ;Cancer. 2015 Apr 15
• 64 citations
  A multicenter phase II study of pazopanib in patients with advanced gastrointestinal stromal tumors (GIST) following failure of at least imatinib and sunitinib
  Kristen N. Ganjoo, Victor M. Villalobos, Aya Kamaya, George A. Fisher, James E. Butrynski, Jeffrey A. Morgan, Andrew J. Wagner, David R. D'Adamo, Alex McMillan, George...> ;Annals of Oncology. 2014 Jan 1
• 62 citations
  Phase 2 trial of aromatase inhibition with letrozole in patients with uterine leiomyosarcomas expressing estrogen and/or progesterone receptors
  Suzanne George, Yang Feng, Judith Manola, Marisa R. Nucci, James E. Butrynski, Jeffrey A. Morgan, Nikhil H. Ramaiya, Richard Quek, Richard T. Penson, Andrew J. Wagner,...> ;Cancer. 2014 Mar 1
• 59 citations
  A Phase I Study of the HSP90 Inhibitor Retaspimycin Hydrochloride (IPI-504) in Patients with Gastrointestinal Stromal Tumors or Soft-Tissue Sarcomas
  Andrew J. Wagner, Rashmi Chugh, Lee S. Rosen, Jeffrey A. Morgan, Suzanne George, Michael S. Gordon, Joi Dunbar, Emmanuel Normant, David Grayzel, George D. Demetri> ;Clinical Cancer Research. 2013 Nov 1
• 9 citations
  Seven-year disease-free survival after radical pneumonectomy for a pulmonary artery sarcoma
  Philip A. Linden, Jeffrey A. Morgan, Gregory S. Couper> ;The Journal of Thoracic and Cardiovascular Surgery. 2013 Sep 1
• 192 citations
  Efficacy and Safety of Regorafenib in Patients With Metastatic and/or Unresectable GI Stromal Tumor After Failure of Imatinib and Sunitinib: A Multicenter Phase II Trial
  Suzanne George, Qian Wang, Michael Heinrich, Christopher L. Corless, Meijun Zhu, James E. Butrynski, Jeffrey A. Morgan, Andrew J. Wagner, Edwin Choy, William D. Tap, J...> ;Journal of Clinical Oncology. 2012 Jul 1
• 23 citations
  Imaging features of bone metastases in patient with gastrointestinal stromal tumors
  Anupma Jati, Servet Tatli, Jeffrey A. Morgan, Jonathan N. Glickman, George D. Demetri, Annick Van Den Abbele, Stuart G. Silverman> ;Diagnostic and Interventional Radiology. 2011 Jan 1
• 33 citations
  Effects of sorafenib on intra-tumoral interstitial fluid pressure and circulating biomarkers in patients with refractory sarcomas (NCI protocol 6948).
  Chandrajit P. Raut, Yves Boucher, Dan G. Duda, Jeffrey A. Morgan, Richard Quek, Marek Ancukiewicz, Johanna Lahdenranta, J. Paul Eder, George D. Demetri, Rakesh K. Jain> ;Plos One. 2012 Feb 7
• A first-in-human phase I study to evaluate GDC-0980, an oral PI3K/mTOR inhibitor, administered QD in patients with advanced solid tumors.
  Wagner AJ, Bendell JC, Dolly S, Morgan JA, Ware JA, Fredrickson J, Mazina KE, Lauchle JO, Burris HA, De Bono JS> ;J. Clin. Oncol.. 2011-05-20
• Accrual of underrepresented minority women to breast cancer clinical trials in the Inland Empire, California.
  Yuan Y, Uppala P, Lum SS, Garberoglio C, Mirshahidi HR, Cassady R, Morgan J, Chen C> ;J. Clin. Oncol.. 2011-05-20
• 126 citations
  Combination mTOR and IGF-1R Inhibition: Phase I Trial of Everolimus and Figitumumab in Patients with Advanced Sarcomas and Other Solid Tumors
  Richard Quek, Qian Wang, Jeffrey A. Morgan, Geoffrey I. Shapiro, James E. Butrynski, Nikhil H. Ramaiya, Tarsha Huftalen, Nicole Jederlinic, Judith Manola, Andrew J. Wa...> ;Clinical Cancer Research. 2011 Feb 15
• 89 citations
  A phase I–II study of everolimus (RAD001) in combination with imatinib in patients with imatinib-resistant gastrointestinal stromal tumors
  Patrick Schöffski, Peter Reichardt, J.-Y. Blay, Herlinde Dumez, Jeffrey A. Morgan, I.L. Ray-Coquard, N. Hollaender, A. Jappe, George D. Demetri> ;Annals of Oncology. 2010 Oct 1
• 269 citations
  Clinical Activity of mTOR Inhibition With Sirolimus in Malignant Perivascular Epithelioid Cell Tumors: Targeting the Pathogenic Activation of mTORC1 in Tumors
  Andrew J. Wagner, Izabela Malinowska-Kolodziej, Jeffrey A. Morgan, Wei Qin, Christopher D.M. Fletcher, Natalie Vena, Azra H. Ligon, Cristina R. Antonescu, Nikhil H. Ra...> ;Journal of Clinical Oncology. 2010 Feb 10
• 54 citations
  Cytoreductive Surgery in Patients with Metastatic Gastrointestinal Stromal Tumor Treated with Sunitinib Malate
  Chandrajit P. Raut, Qian Wang, Judith Manola, Jeffrey A. Morgan, Suzanne George, Andrew J. Wagner, James E. Butrynski, Christopher D.M. Fletcher, George D. Demetri, Mo...> ;Annals of Surgical Oncology. 2010 Feb 1
• 23 citations
  Recognition of a New Chemotherapeutic Vesicant: Trabectedin (Ecteinascidin-743) Extravasation With Skin and Soft Tissue Damage
  Todd A. Theman, Tristan L. Hartzell, Indranil Sinha, Kathleen Polson, Jeffrey A. Morgan, George D. Demetri, Dennis P. Orgill, Suzanne George> ;Journal of Clinical Oncology. 2009 Nov 20
• Join now to see all